Your browser doesn't support javascript.
loading
Antiandrogen abiraterone and docetaxel treatments affect Notch1, Jagged1 and Hes1 expressions in metastatic prostate cancer cells.
Soylu, Hakan; Kirca, Mustafa; Avci, Sema; Ozpolat, Bulent; Ustunel, Ismail.
Affiliation
  • Soylu H; Department of Histology and Embryology, Faculty of Medicine, Duzce University, 81620 Duzce, Turkey.
  • Kirca M; Department of Biochemistry, Faculty of Medicine, Kutahya Health Sciences University, 43100 Kutahya, Turkey.
  • Avci S; Department of Histology and Embryology, Faculty of Medicine, Alanya Alaaddin Keykubat University, 07070 Antalya, Turkey.
  • Ozpolat B; Department of Experimental Therapeutics, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.
  • Ustunel I; Department of Histology and Embryology, Faculty of Medicine, Akdeniz University, 07070 Antalya, TURKEY. Electronic address: iustunel@akdeniz.edu.tr.
Exp Mol Pathol ; 119: 104607, 2021 04.
Article in En | MEDLINE | ID: mdl-33482170

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Receptor, Notch1 / Jagged-1 Protein / Transcription Factor HES-1 / Docetaxel / Androgen Antagonists / Androstenes Type of study: Prognostic_studies Limits: Humans / Male Language: En Journal: Exp Mol Pathol Year: 2021 Document type: Article Affiliation country: Turkey

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Receptor, Notch1 / Jagged-1 Protein / Transcription Factor HES-1 / Docetaxel / Androgen Antagonists / Androstenes Type of study: Prognostic_studies Limits: Humans / Male Language: En Journal: Exp Mol Pathol Year: 2021 Document type: Article Affiliation country: Turkey